Dataset Information

Regulatory T-Cells Mediate IFN-?-Induced Resistance against Antigen-Induced Arthritis.

ABSTRACT:

Objective

CD4⁺FoxP3⁺CD25⁺ regulatory T-cells (T_regs) are important for preventing tissue destruction. Here, we investigate the role of T_regs for protection against experimental arthritis by IFN-?.

Methods

Arthritis was triggered by intra-articular injection of methylated bovine serum albumin (mBSA) in wild-type mice, Foxp3DTReGFP^+/- mice [allowing selective depletion of T_regs by diphtheria toxin (DT)] and CD4-Cre^+/- IFNA1R flox/flox mice (devoid of IFNAR signaling in T-cells) earlier immunized with mBSA, with or without treatment with IFN-? or the indoleamine 2,3-dioxygenase (IDO)-metabolite kynurenine. T_regs were depleted in DT-treated Foxp3DTReGFP^+/- mice and enumerated by FoxP3 staining. Suppressive capacity of FACS-sorted CD25^+highCD4⁺ T_regs was tested in vivo by adoptive transfer and ex vivo in cocultures with antigen-stimulated CFSE-stained T-responder (CD25^-CD4⁺) cells. IDO was inhibited by 1-methyl tryptophan.

Results

Both control mice and mice devoid of IFNAR-signaling in T helper cells were protected from arthritis by IFN-?. Depletion of T_regs in the arthritis phase, but not at immunization, abolished the protective effect of IFN-? and kynurenine against arthritis. IFN-? increased the number of T_regs in ex vivo cultures upon antigen recall stimulation but not in naïve cells. IFN-? also increased the suppressive capacity of T_regs against mBSA-induced T-responder cell proliferation ex vivo and against arthritis when adoptively transferred. The increased suppressive activity against proliferation conferred by IFN-? was clearly reduced by in vivo inhibition of IDO at immunization, which also abolished the protective effect of IFN-? against arthritis.

Conclusion

By activating IDO during antigen sensitization, IFN-? activates T_regs, which prevent arthritis triggered by antigen rechallenge. This is one way by which IFN-? suppresses inflammation.

SUBMITTER: Chenna Narendra S

PROVIDER: S-EPMC5826073 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Regulatory T-Cells Mediate IFN-α-Induced Resistance against Antigen-Induced Arthritis.

Chenna Narendra Sudeep S Chalise Jaya Prakash JP Biggs Sophie S Kalinke Ulrich U Magnusson Mattias M

Frontiers in immunology 20180219

<h4>Objective</h4>CD4<sup>+</sup>FoxP3<sup>+</sup>CD25<sup>+</sup> regulatory T-cells (T<sub>regs</sub>) are important for preventing tissue destruction. Here, we investigate the role of T<sub>regs</sub> for protection against experimental arthritis by IFN-α.<h4>Methods</h4>Arthritis was triggered by intra-articular injection of methylated bovine serum albumin (mBSA) in wild-type mice, Foxp3DTReGFP<sup>+/-</sup> mice [allowing selective depletion of T<sub>regs</sub> by diphtheria toxin (DT)] and ...[more]

PMID: 29515584

Similar Datasets

Project description:Regulatory T (Treg) cells have anti-inflammatory functions and heighten immune tolerance. The proportion and functions of Treg cells are perturbed in rheumatoid arthritis (RA), contributing to the excessive immune activation associated with this disease. We therefore hypothesized that supplementation with foreign Treg cells could be used to treat RA. To investigate the therapeutic effects of exogenous Treg cells on RA and its mechanism, we used human Treg cells to treat collagen-induced arthritis (CIA) in a rat model to observe whether exogenous Treg cells can treat the disease across species. Successful treatment would indicate that Treg cell transplantation in humans is more likely to affect RA. In the present study, human Treg cells were collected from healthy human peripheral blood and culture-expanded in vitro. Induced human Treg cells were injected into CIA rats via the tail vein. The rats' lymphocyte subtypes, cytokines, and Th1/Th2 ratios were measured using flow cytometry. In the rats, following injection of the human Treg cells, the severity of CIA was significantly reduced (P < 0.01), the proportion of endogenous Treg cells increased in the peripheral blood and spleen (P = 0.007 and P < 0.01, respectively), and the proportion of B cells decreased (P = 0.031). The IL-5 level, IL-6 level, and Th1/Th2 ratio in the peripheral blood were decreased (P = 0.013, 0.009, and 0.012, respectively). The culture-expanded human Treg cells were also cultured with synovial fibroblast cells from RA patients (RASFs). After coculture with Treg cells, RASFs showed reduced proliferation (P < 0.01) and increased apoptosis (P = 0.037). These results suggest that exogenous and induced Treg cells can produce a therapeutic effect in RA and CIA by increasing endogenous Treg cells and RASF apoptosis and reducing B cells, the Th1/Th2 ratio, and secretion levels of IL-5 and IL-6. Treg cell transplantation could serve as a therapy for RA that does not cause immune rejection.